A Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser
A Prospective Randomized Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser
1 other identifier
interventional
137
1 country
1
Brief Summary
Subjects with myopia, hyperopia and astigmatism are being randomized to be treated in one eye with a wavefront-guided excimer laser and their fellow eye treated with a wavefront-optimized excimer laser.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 8, 2009
CompletedFirst Posted
Study publicly available on registry
June 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 3, 2022
CompletedDecember 7, 2022
December 1, 2022
4.8 years
May 8, 2009
December 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in best spectacle corrected visual acuity.
One year
Changes in 25 and 5% low contrast visual acuity.
One year
Improvement in uncorrected visual acuity
One year
Secondary Outcomes (3)
Changes in higher order aberrations.
One year
Topographic changes.
One year
Quality of vision changes.
One year
Study Arms (2)
Wavefront guided LASIK/PRK
ACTIVE COMPARATORWavefront-guided LASIK/PRK
Wavefront optimized LASIK/PRK
ACTIVE COMPARATORWavefornt optimized LASIK/PRK
Interventions
Wavefront-guided versus wavefront-optimized LASIK or PRK.
Eligibility Criteria
You may qualify if:
- Healthy subjects age 21 and older.
- Subjects with nearsightedness, farsightedness and/or astigmatism.
You may not qualify if:
- Children.
- Women pregnant or nursing.
- Ectatic corneal disease.
- Previous ocular surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Edward E. Manchelead
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
Related Publications (6)
Smith RG, Manche EE. One-Year Outcomes From a Prospective, Randomized, Eye-to-Eye Comparison of Wavefront-Guided and Wavefront-Optimized PRK in Myopia. J Refract Surg. 2020 Mar 1;36(3):160-168. doi: 10.3928/1081597X-20200129-01.
PMID: 32159820BACKGROUNDLee MD, Toy BC, Manche EE. Astigmatic outcomes in myopic wavefront-guided laser in situ keratomileusis versus wavefront-guided photorefractive keratectomy using vector analysis. J Cataract Refract Surg. 2018 Nov;44(11):1350-1354. doi: 10.1016/j.jcrs.2018.07.022. Epub 2018 Sep 7.
PMID: 30201128BACKGROUNDHe L, Manche EE. Contralateral eye-to-eye comparison of wavefront-guided and wavefront-optimized photorefractive keratectomy: a randomized clinical trial. JAMA Ophthalmol. 2015 Jan;133(1):51-9. doi: 10.1001/jamaophthalmol.2014.3876.
PMID: 25321951BACKGROUNDKung JS, Manche EE. Quality of Vision After Wavefront-Guided or Wavefront-Optimized LASIK: A Prospective Randomized Contralateral Eye Study. J Refract Surg. 2016 Apr;32(4):230-6. doi: 10.3928/1081597X-20151230-01.
PMID: 27070229BACKGROUNDHe L, Liu A, Manche EE. Wavefront-guided versus wavefront-optimized laser in situ keratomileusis for patients with myopia: a prospective randomized contralateral eye study. Am J Ophthalmol. 2014 Jun;157(6):1170-1178.e1. doi: 10.1016/j.ajo.2014.02.037. Epub 2014 Feb 19.
PMID: 24560995BACKGROUNDSales CS, Manche EE. One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes. Clin Ophthalmol. 2014 Nov 12;8:2229-38. doi: 10.2147/OPTH.S70145. eCollection 2014.
PMID: 25419115BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edward E. Manche
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Stanford University School of Medicine
Study Record Dates
First Submitted
May 8, 2009
First Posted
June 3, 2010
Study Start
April 1, 2009
Primary Completion
December 31, 2013
Study Completion
December 3, 2022
Last Updated
December 7, 2022
Record last verified: 2022-12